检索结果-南通市图书馆

Chinese national clinical practice guidelines on the prevention,diagnosis,and treatment of early gastric cancer

在线全文

学校读者我要写书评

暂无评论

Chinese Medical Journal 2024年第8期137卷 887-908页

作者： Peng Li Ziyu Li Enqiang Linghu Jiafu Ji Society of digestive Endoscopy of the Chinese Medical Association Colorectal Surgery Group of the Chinese Medical Association Chinese Association of Gastroenterologists&Hepatologists national clinical Research {3. for digestive diseases Chinese Medical Journal clinical Practice Guideline Collaborative Department of Gastroenterology Beijing Friendship HospitalCapital Medical UniversityNational Clinical Research Center for Digestive DiseaseBeijing 100050China Department of Gastrointestinal Surgery Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education)Peking University Cancer Hospital and InstituteBeijing 100142China Department of Gastroenterology and Hepatology the First Medical CenterChinese People’s Liberation Army General HospitalBeijing 100853China 不详

Background:Gastric cancer is one of the most common malignant tumors in the digestive system in *** comprehensive practice guidelines for early gastric cancer in China are currently ***,we created the Chinese national clinical practice guideline for the prevention,diagnosis,and treatment of early gastric ***:This clinical practice guideline(CPG)was developed in accordance with the World Health Organization’s recommended process and with the Grading of Recommendations Assessment,Development,and Evaluation(GRADE)in assessing evidence *** used the Evidence to Decision framework to formulate clinical recommendations to minimize bias and increase transparency in the CPG development *** used the Reporting Items for practice Guidelines in HealThcare(RIGHT)statement and the Appraisal of Guidelines for Research and Evaluation II(AGREE II)as reporting and conduct guidelines to ensure completeness and transparency of the ***:This CPG contains 40 recommendations regarding the prevention,screening,diagnosis,treatment,and follow-up of early gastric cancer based on available clinical studies and *** provide recommendations for the timing of Helicobacter pylori eradication,screening populations for early gastric cancer,indications for endoscopic resection and surgical gastrectomy,follow-up interval after treatment,and other ***:This CPG can lead to optimum care for patients and populations by providing up-to-date medical *** intend this CPG for widespread adoption to increase the standard of prevention,screening,diagnosis,treatment,and follow-up of early gastric cancer;thereby,contributing to improving national health care and patient quality of life.

关键词： Early gastric cancer Prevention Screening Diagnosis Treatment Follow-up

Report on Cardiovascular Health and diseases in China 2023.An Updated Summary

在线全文

学校读者我要写书评

暂无评论

Biomedical and Environmental Sciences 2024年第9期37卷 949-992页

作者： national center for Cardiovascular diseases The Writing Committee of the Report on Cardiovascular Health and diseases in China Shengshou Hu .

Since 1990,China has made considerable progress in resolving the problem of“treatment difficulty”of cardiovascular diseases(CVD).The prevalent unhealthy lifestyle among Chinese residents has exposed a massive proportion of the population to CVD risk factors,and this situation is further worsened due to the accelerated aging population in *** remains one of the greatest threats to the health of Chinese *** terms of the proportions of disease mortality among urban and rural residents in China,CVD has persistently ranked *** 2021,CVD accounted for 48.98%and 47.3.%of deaths in rural and urban areas,*** out of every five deaths can be attributed to *** implement a national policy“focusing on the primary health institute and emphasizing prevention”and truly achieve a shift of CVD prevention and treatment from hospitals to communities,the national {3. for Cardiovascular diseases has organized experts from relevant fields across China to compile the“Report on Cardiovascular Health and diseases in China”annually since *** 2024 report is established based on representative,published,and high-quality big-data research results from cross-sectional and cohort population epidemiological surveys,randomized controlled clinical trials,large sample registry studies,and typical community prevention and treatment cases,along with data from some projects undertaken by the national {3. for Cardiovascular *** firsthand data not only enrich the content of the current report but also provide a more timely and comprehensive reflection of the status of CVD prevention and treatment in China.

关键词： Cardiovascular disease Risk factor Prevalence Mortality Rehabilitation Basic research Medical device development Health economics

Chinese national clinical practice guidelines on prevention,diagnosis and treatment of early colorectal cancer

在线全文

学校读者我要写书评

暂无评论

Chinese Medical Journal 2024年第17期137卷 2017-2039页

作者： Jingnan Li Hongwei Yao Yun Lu Shutian Zhang Zhongtao Zhang Society of digestive Endoscopy of the Chinese Medical Association Colorectal Surgery Group of the Chinese Medical Association Chinese Association of Gastroenterologist&Hepatologist national clinical Research {3. for digestive diseases Chinese Medical Journal clinical Practie Guideline Collaborative Department of Gastroenterology Peking Union Medical College HospitalChinese Academy of Medical SciencesPeking Union Medical CollegeBeijing 100730China Department of General Surgery Beijing Friendship HospitalCapital Medical UniversityNational Clinical Research Center for Digestive DiseasesBeijing 100050China Department of General Surgery The Affiliated Hospital of Qingdao UniversityQingdaoShandong 266555China Department of Gastroenterology Beijing Friendship HospitalCapital Medical UniversityNational Clinical Research Center for Digestive DiseaseBeijing 100050China 不详

Background:The incidence and mortality of colorectal cancer(CRC)in China are increasing in recent *** clarified pathogenesis and detectable precancerous lesions of CRC make it possible to prevent,screen,and diagnose CRC at an early *** the development of endoscopic and surgical techniques,the choice of treatment for early CRC is also worth further discussion,and accordingly,a standard follow-up program after treatment needs to be ***:This clinical practice guideline(CPG)was developed following the recommended process of the World Health Organization,adopting Grading of Recommendations Assessment,Development and Evaluation(GRADE)in assessing evidence quality,and using the Evidence to Decision framework to formulate clinical recommendations,thereby minimizing bias and increasing transparency of the CPG development *** used the Reporting Items for practice Guidelines in HealThcare(RIGHT)statement and Appraisal of Guidelines for Research and Evaluation II(AGREE II)as reporting and conduct guides to ensure the guideline’s completeness and ***:This CPG comprises 46 recommendations concerning prevention,screening,diagnosis,treatment,and surveillance of *** these recommendations,we have indicated protective and risk factors for CRC and made recommendations for *** proposed a suitable screening program for CRC based on the Chinese *** also provided normative statements for the diagnosis,treatment,and surveillance of CRC based on existing clinical evidence and ***:The 46 recommendations in this CPG are formed with consideration for stakeholders’values and preferences,feasibility,and *** are generalizable to resource-limited settings with similar CRC epidemiology pattern as China.

关键词： Colorectal cancer Early detection of cancer Prevention Screening Diagnosis Treatment Follow-up Guideline

胸腺法新在感染和重症相关领域临床应用专家共识

在线全文

学校读者我要写书评

暂无评论

中华临床感染病杂志 2024年第4期17卷 252-262页

作者：国家感染性疾病临床医学研究中心国家传染病医学中心

随着免疫治疗被越来越多的临床医师关注和应用, 免疫调节治疗在感染和重症领域的应用也越来越广泛。作为免疫调节治疗的经典药物, 胸腺法新在相关治疗领域已积累了较多临床证据。国家感染性疾病临床医学研究中心和国家传染病医学中心等... 详细信息

随着免疫治疗被越来越多的临床医师关注和应用, 免疫调节治疗在感染和重症领域的应用也越来越广泛。作为免疫调节治疗的经典药物, 胸腺法新在相关治疗领域已积累了较多临床证据。国家感染性疾病临床医学研究中心和国家传染病医学中心等组织多学科专家, 参照国内外最新研究成果, 参考基于证据质量以外的其他因素(经济学、患者偏好和价值观、利弊权衡、可及性、公平性及可接受性等)对循证医学证据的等级和推荐意见强度进行评估, 形成了10条应用胸腺法新治疗肝病、病毒感染、细菌感染, 以及重症感染等疾病的推荐意见, 从而希望增进临床医师对胸腺法新的了解, 提高临床应用的规范性。

关键词：胸腺法新感染性疾病危重症临床应用共识

Expert Consensus on the Prevention and Treatment of Chronic Hepatitis B in Children

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

Infectious diseases & Immunity 2024年第3期4卷 106-120页

作者： Chinese Society of Infectious diseases Chinese Medical Association Chinese Society of Hepatology Chinese Medical Association Group of Infectious diseases Chinese Pediatric Society Chinese Medical Association national {3. Research center for Infectious diseases(Beijing) Fu-Sheng Wang Shishu Zhu Min Zhang Jianshe Wang Shuangjie Li Junliang Fu Yuanyuan Li Yuming Guo Jing Li Hongmei Xu Wenxian Ouyang Yuemin Nan Sainan Shu Shuangsuo Dang Xiaoyuan Xu Taisheng Li Jinlin Hou 不详 The Fifth Medical center of PLA General Hospital Beijing 100039China Fudan University Children’s Hospital Hunan Children’s Hospital Children’s Hospital of Chongqing Medical University Third Hospital Hebei Medical University Tongji Hospital Tongji Medical CollegeHuazhong University of Science and Technology The Second Affiliated Hospital of Xi’an Jiaotong University Peking University First Hospital Peking Union Medical College Hospital Chinese Academy of Medical Sciences&Peking Union Medical College Nanfang Hospital Southern Medical University

The aim of this consensus is to standardize the prevention, diagnosis, and treatment of chronic hepatitis B in children and to achieve the goal of “eliminating viral hepatitis as a major public health threat by 203.” issued by the World Health Organization. Formulated by organized experts of the Chinese Society of Infectious diseases and Chinese Society of Hepatology, Chinese Medical Association;Group of Infectious diseases, Chinese Pediatric Society, Chinese Medical Association;and the national {3. Research center for Infectious diseases (Beijing), the consensus provides the latest evidence and recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B in children.

关键词： Chronic hepatitis B Children Treatment Prevention Consensus

Consensus of Chinese experts on glioma multidisciplinary team management(2nd edition)

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Chinese Medical Journal 2024年第11期137卷 1267-1270页

作者： Jinsong Wu Zhirui Zhou Zanyi Wu Zhiwei Tang Ming Li Siyuan Yin Xufei Luo Ling Wang Yaolong Chen Guoguang Zhao Tao Jiang Ying Mao The national Glioma MDT Alliance of national center for Neurological {3. Department of Neurosurgery Huashan HospitalShanghai Medical CollegeFudan UniversityShanghai 200040China Department of Radiation Oncology Huashan HospitalShanghai Medical CollegeFudan UniversityShanghai 200040China Department of Neurosurgery The First Affiliated Hospital of Fujian Medical UniversityFuzhouFujian 350005China Neurosurgery Department The First Affiliated Hospital of Kunming Medical UniversityKunmingYunnan 650032China Department of Neurosurgery Henan Provincial People’s HospitalPeople’s Hospital of Zhengzhou UniversityZhengzhouHenan 463599China State Key Laboratory of Pharmaceutical Biotechnology Institute for Brain SciencesAdvanced Institute for Life SciencesSchool of Life SciencesNanjing UniversityNanjingJiangsu 210023China Evidence-Based Medicine center School of Basic Medical SciencesLanzhou UniversityLanzhouGansu 730000China School of Public Health Lanzhou UniversityLanzhouGansu 730000China Department of Neurosurgery Xuanwu HospitalCapital Medical UniversityBeijing 100053China Department of Neurosurgery Beijing Tiantan HospitalCapital Medical UniversityBeijing 100050China 不详

To increase the consistency of glioma multidisciplinary team(MDT)management across different regions and hospitals at varying levels,we have updated the Expert Consensus on MDT of Glioma in China based on the currently available *** version has revised and updated the process-management rules and quality-control standards for a glioma MDT,providing reference and guidance for relevant clinical disciplines and *** members of the Consensus Expert Group,abstract,background,and prospects can be seen in supplementaryle,http://***/CM9/B999.

关键词： glioma MDT Expert

中国结直肠肿瘤无创诊断生物标志物应用专家共识(2023.北京)

在线全文

学校读者我要写书评

暂无评论

中华消化内镜杂志 2024年第3期41卷 169-177页

作者：消化健康全国重点实验室国家消化系统疾病临床医学研究中心中国医师协会消化医师分会施海韵李鹏张澍田不详首都医科大学附属北京友谊医院消化内科北京100050

结直肠癌是常见的恶性肿瘤之一,在我国的发病率仍呈上升趋势。通过筛查发现结直肠腺瘤或早期结直肠癌是降低结直肠癌发病率和死亡率的前提和关键。随着结直肠肿瘤无创诊断生物标志物的临床应用不断增多,以及相关研究证据的不断积累,国... 详细信息

结直肠癌是常见的恶性肿瘤之一,在我国的发病率仍呈上升趋势。通过筛查发现结直肠腺瘤或早期结直肠癌是降低结直肠癌发病率和死亡率的前提和关键。随着结直肠肿瘤无创诊断生物标志物的临床应用不断增多,以及相关研究证据的不断积累,国家消化系统疾病临床医学研究中心牵头,依托消化健康全国重点实验室,联合中国医师协会消化医师分会,组织我国消化内外科、消化内镜和肿瘤领域专家共同制定了本共识,以期为我国结直肠肿瘤无创诊断生物标志物的临床应用提供指导和参考。

关键词：结直肠肿瘤生物学标记,肿瘤无创诊断粪便微生物标志物粪便肿瘤基因标志物专家共识

基于医用直线加速器开展脑转移瘤立体定向放射治疗的质量控制和质量保证

在线全文

学校读者我要写书评

暂无评论

中华放射肿瘤学杂志 2024年第5期33卷 383-396页

作者：国家癌症中心/国家肿瘤质控中心李光不详中国医科大学附属第一医院放射治疗科沈阳110002

立体定向放射治疗(SRT)具有单次照射剂量大、分割次数少、边缘剂量下降快的特点,是治疗脑转移瘤的重要手段。目前基于直线加速器开展的脑转移瘤立体定向放射外科或SRT技术较伽马刀和射波刀经济适用、性价比更高,临床应用更广泛。本指南... 详细信息

立体定向放射治疗(SRT)具有单次照射剂量大、分割次数少、边缘剂量下降快的特点,是治疗脑转移瘤的重要手段。目前基于直线加速器开展的脑转移瘤立体定向放射外科或SRT技术较伽马刀和射波刀经济适用、性价比更高,临床应用更广泛。本指南以已发布的国内外相关标准为依据,聚焦于基于直线加速器开展的SRT技术在临床实践工作所涉及的各个环节,以期帮助国内放疗单位正确安全地运用SRT技术。

关键词：肿瘤转移,脑立体定向放射疗法直线加速器质量控制质量保证

在线全文

学校读者我要写书评

暂无评论

放射治疗相关的器官运动管理指南

中华放射肿瘤学杂志 2024年第3期33卷 189-196页

作者：国家癌症中心/国家肿瘤质控中心陈明不详华南恶性肿瘤防治全国重点实验室广东省鼻咽癌诊治研究重点实验室广东省恶性肿瘤临床医学研究中心中山大学肿瘤防治中心中山大学-国科离子放射治疗前沿技术联合实验室广州510060

肿瘤定位的准确性是实现精准放射治疗的关键。器官运动是肿瘤定位的主要误差来源。不同部位肿瘤的运动类型不同,相应的管理策略也有所差异。本指南系统总结了头颈部、胸部、腹部、盆腔部的常见肿瘤疾病的器官运动来源,以及现行的运动管... 详细信息

肿瘤定位的准确性是实现精准放射治疗的关键。器官运动是肿瘤定位的主要误差来源。不同部位肿瘤的运动类型不同,相应的管理策略也有所差异。本指南系统总结了头颈部、胸部、腹部、盆腔部的常见肿瘤疾病的器官运动来源,以及现行的运动管理方法。针对基于医用电子直线加速器开展的放射治疗,本指南依据肿瘤所处的部位差异,给出了相应的运动管理建议,旨在为已开展或即将开展放射治疗临床实践的单位提供参考的指南依据,以便正确、合理地制订器官运动管理方案,提升放疗实施的准确性,保证治疗疗效。

关键词：放射疗法器官运动管理指南